Pueraria lobata peptides ameliorate type 1 diabetes with involvement of the gut-pancreas axis: Insights from intestinal barrier, gut microbiota, and pancreatic protection.
This study aimed to investigate the intervention effects of Pueraria lobata peptides (PLPs) on type 1 diabetes (T1D) and elucidate the underlying mechanisms from the perspective of the "gut-pancreas axis." In a streptozotocin (STZ)-induced T1D mouse model, an 8-week PLPs intervention (particularly at 400 mg/kg/day) sig...